This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Coley Pharmaceutical Group, Inc.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations in Pneumococcal Vaccines by Henrik Carl Schonheyder
Introduction
Henrik Carl Schonheyder is a notable inventor based in Aalborg, Denmark. He has made significant contributions to the field of immunology, particularly in the development of pneumococcal vaccines. His work focuses on creating effective solutions for immunocompromised individuals who are at higher risk for pneumococcal infections.
Latest Patents
Henrik holds a patent for a novel pneumococcal vaccine and its uses. The patent details a new approach to vaccination, specifically targeting subjects who are immunocompromised. This innovative vaccine aims to provide better protection against pneumococcal infections, which can be particularly severe in vulnerable populations.
Career Highlights
Henrik is associated with Coley Pharmaceutical Group, Inc., where he continues to advance his research in vaccine development. His work has been instrumental in addressing public health challenges related to pneumococcal diseases.
Collaborations
Henrik has collaborated with notable colleagues, including Heather Lynn Davis and Arthur Mertz Krieg. These partnerships have enhanced the research and development process, leading to more effective vaccine solutions.
Conclusion
Henrik Carl Schonheyder's contributions to the field of pneumococcal vaccines represent a significant advancement in immunology. His innovative approach and dedication to improving health outcomes for immunocompromised individuals are commendable.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile